Previous close | 8.75 |
Open | 8.95 |
Bid | 8.56 x 800 |
Ask | 8.99 x 900 |
Day's range | 8.54 - 9.20 |
52-week range | 4.00 - 9.86 |
Volume | |
Avg. volume | 377,445 |
Market cap | 266.86M |
Beta (5Y monthly) | 0.08 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Neurocrine (NBIX) delivered earnings and revenue surprises of -9.89% and 4.01%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?